Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Cell. Neurosci.

Sec. Cellular Neuropathology

Volume 19 - 2025 | doi: 10.3389/fncel.2025.1670462

This article is part of the Research TopicNeuro-immune interaction in diseaseView all 3 articles

Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration

Provisionally accepted
  • 1Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Institute (PAS), Warsaw, Poland
  • 2Xinxiang Medical University, Xinxiang, China
  • 3Department of Pathophysiology, Medical University of Lublin, Lublin, Poland

The final, formatted version of the article will be published soon.

Post-ischemic brain neurodegeneration with subsequent neuroinflammation is a major cause of mortality, permanent disability, and the development of Alzheimer's disease type dementia in the absence of appropriate treatment. The inflammatory response begins immediately after ischemia and can persist for many years. Post-ischemic neuroinflammation plays a dual role: initially, it is essential for brain repair and maintenance of homeostasis, but when it becomes uncontrolled, it causes secondary damage and worsens neurological outcome. Neuroinflammation is a complex phenomenon involving interactions between infiltrating immune cells from the peripheral circulation and resident immune cells in ischemic brain areas. This review focuses on the complex relationship between non-coding RNAs, amyloid accumulation, tau protein modifications, and the development of neuroinflammation in the post-ischemic brain. In particular, it clarifies whether the cooperation of non-coding RNAs with amyloid and tau protein enhances neuroinflammation and whether the vicious cycle of neuroinflammatory responses affects the production, behavior, and aggregation of these molecules. Ultimately, elucidating these interactions is critical, as they may contribute to resolving the phenomenon of post-ischemic brain neurodegenerative mechanisms. Furthermore, this review highlights the role of neuroinflammation as a functionally complex immune response regulated/mediated by transcription factors and cytokines. Additionally, it examines how the presence of non-coding RNAs, amyloid aggregation, and modified tau protein may shape the inflammatory landscape. This review aims to advance our understanding of post-ischemic neuroinflammation and its implications for long-term brain health.

Keywords: Brain Ischemia, Neuroinflammation, non-coding RNAs, micro RNAs, circular RNAs, Long-non-coding RNAs, Amyloid, tau protein

Received: 21 Jul 2025; Accepted: 17 Oct 2025.

Copyright: © 2025 Pluta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ryszard Pluta, pluta2018@wp.pl

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.